Assessment of Serum (YKL-40) As an Early Diagnostic Marker of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus

Evaluation of YKL-40 in Patients with Type II Diabetes Mellitus with Increasing Levels of Albuminuria

The Anti-Diabetic, Lipidemic, And Pro-Inflammatory Effects of oral hypoglycemic on T2DM Obese Patients

Study of Serum Betatrophin Level as a Biochemical Marker in Patients with Type-2 Diabetes Mellitus

𝛼-2-Macroglobulin in Saliva as A Glycemic Control Marker in Type 2 Diabetes Mellitus Patients

Effect of Glycemic Control Using Different Antidiabetic Drugs on Cognitive Functions in Experimentally-Induced Type 2DM: A Comparative Study

Alpha-2-Macroglobulin in Saliva as a Noninvasive Glycemic Control Marker in Type 2 Diabetes Mellitus Patients

Assessment of SH3YL1 protein as a marker for diabetic nephropathy in type 2 diabetes mellitus

Levels of chemerin and asymmetric dimethylarginine (ADMA) in obese type 2 diabetic patients.

Assessment of SerumYkl-40 and High Sensitivity C-Reactive Protein as Biomarkers of Renal Affection of Children with Type 1 Diabetes